Applied Biosciences Corp.
- Tampa, Florida, United States
Applied Biosciences Corp. Employees
Applied Biosciences Corp. Senior Management
Applied Biosciences Corp. Details
Oxis International, Inc. (OTCQB: OXIS and EURONEXT PARIS OXI.PA), through its wholly owned subsidiary Oxis Biotech, Inc., is engaged in the development of immunotherapies for the treatment of cancer. Oxis' lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer. In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis. Oxis' lead drug candidate, OXS-4235, also a small molecule therapeutic candidate, targets the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone.
Applied Biosciences Corp. Technologies
Retargeting
AdRoll
Ad Servers
DoubleClick
Email Providers
Outlook
Load Balancers
Apache
Hosting
DigitalOcean
Analytics and Tracking
Google Analytics